Colin advises clients throughout their lifecycle (all the way from start-up/spin-out to multinational listed companies) on the commercialisation of their intellectual property rights. In particular, advising on licensing deals, collaborations and R&D projects, distribution and manufacturing and the IP, commercial and regulatory aspects of M&A, VC investments and IPOs.

Having a 1st class degree in Cell Biology his practice has naturally become focused on the life sciences, healthcare and technology (with a particular focus on med-tech and clean-tech) sectors.

显示完整简历 隐藏完整简历

最新新闻和观点

pipette
Synapse

Arbitration for life sciences companies

29 六月 2020
IN-DEPTH ANALYSIS

作者

点击此处了解更多
centrifuge-machine
Synapse

Territorial licensing: "start at the end before you begin"

25 六月 2020
IN-DEPTH ANALYSIS

作者 Colin McCall 以及 Justyna Ostrowska

点击此处了解更多
pipette
Synapse

新冠疫情(COVID-19)对全球生命科学领域并购的影响

16 四月 2020
阅读全文

作者

点击此处了解更多
Overhead view of scientist using centrifuge machine
酒店与休闲

Advising Glenmark on product portfolio sale

7 四月 2020

作者

点击此处了解更多

与我会面: